Highlights

• Mayne Pharma rallied last week after agreeing to offload its international business, including its Adelaide manufacturing site. As Mayne Pharma continues operating within the All Ordinaries, growing attention is also being directed towards ASX Technical Analysis as companies across the sector navigate changing market conditions.
• For readers following the ASX All Ords and ASX news today, Mayne Pharma remains among the stocks to watch.
• The deal turns the group into an United States-focused company and has revived market talk about the future of that business.
• Chart watchers want to see whether the jump can turn a weak post-quarter setup into a…